The logo of Swiss drugmaker Novartis is seen at its headquarters in Basel October 22, 2013. REUTERS/Arnd Wiegmann ZURICH (Reuters) - Swiss pharmaceutical group Novartis said on Tuesday the European ...
Please provide your email address to receive an email when new articles are posted on . HUENENBERG, Switzerland — The U.S. Food and Drug Administration has approved Travatan Z ophthalmic solution for ...
Travoprost 0.004%; oph soln; contains sofZia (boric acid, propylene glycol, sorbitol, zinc chloride). Do not exceed recommended dose. Active intraocular inflammation. Aphakia. Pseudophakia with torn ...
Glenmark Pharmaceuticals is introducing travoprost ophthalmic solution, 0.004% (ionic buffered solution), which is the generic of Sandoz’s Travatan Z. The medication is indicated for glaucoma and ...
A convention graphic for Alcon’s Travatan Z, an ophthalmic drop, broadened the product’s indication and made unsubstantiated superiority claims, according to a Division of Drug Marketing, Advertising ...
Travoprost Ophthalmic Solution, 0.004%, is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. Lupin has received approval from ...
ZURICH (Reuters) - Swiss pharmaceutical group Novartis said on Tuesday the European Commission had approved an additional treatment for its eyecare unit Alcon's Travatan treatment for glaucoma, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback